Abstract

BackgroundBetween 2002 and 2010, the Global Fund to Fight AIDS, Tuberculosis and Malaria's investment in HIV increased substantially to reach US$12 billion. We assessed how the Global Fund's investments in HIV programmes were targeted to key populations in relation to disease burden and national income.MethodsWe conducted an assessment of the funding approved by the Global Fund Board for HIV programmes in Rounds 1-10 (2002-2010) in 145 countries. We used the UNAIDS National AIDS Spending Assessment framework to analyze the Global Fund investments in HIV programmes by HIV spending category and type of epidemic. We examined funding per capita and its likely predictors (HIV adult prevalence, HIV prevalence in most-at-risk populations and gross national income per capita) using stepwise backward regression analysis.ResultsAbout 52% ($6.1 billion) of the cumulative Global Fund HIV funding was targeted to low- and low-middle-income countries. Around 56% of the total ($6.6 billion) was channelled to countries in sub-Saharan Africa. The majority of funds were for HIV treatment (36%; $4.3 billion) and prevention (29%; $3.5 billion), followed by health systems and community systems strengthening and programme management (22%; $2.6 billion), enabling environment (7%; $0.9 billion) and other activities. The Global Fund investment by country was positively correlated with national adult HIV prevalence. About 10% ($0.4 billion) of the cumulative HIV resources for prevention targeted most-at-risk populations.ConclusionsThere has been a sustained scale up of the Global Fund's HIV support. Funding has targeted the countries and populations with higher HIV burden and lower income. Prevention in most-at-risk populations is not adequately prioritized in most of the recipient countries. The Global Fund Board has recently modified eligibility and prioritization criteria to better target most-at-risk populations in Round 10 and beyond. More guidance is being provided for Round 11 to strategically focus demand for Global Fund financing in the present resource-constrained environment.

Highlights

  • Between 2002 and 2010, the Global Fund to Fight AIDS, Tuberculosis and Malaria’s investment in HIV increased substantially to reach US$12 billion

  • Conceptual framework The conceptual framework for this assessment is an analysis of funding flows and resource allocation patterns, using the National AIDS Spending Assessment (NASA) framework [4,5], developed by the Joint United Nations Programme on AIDS (UNAIDS)

  • The Global Fund resource allocation model allows for the scale up of investment in HIV prevention, treatment, care and support programmes, and its funding is aligned with HIV burden and national income

Read more

Summary

Introduction

Between 2002 and 2010, the Global Fund to Fight AIDS, Tuberculosis and Malaria’s investment in HIV increased substantially to reach US$12 billion. The Global Fund to Fight AIDS, Tuberculosis and Malaria is a public-private partnership dedicated to attracting and disbursing resources to address HIV, tuberculosis (TB) and malaria pandemics. As of the end of 2010, the Global Fund had allocated US$12 billion and disbursed $7.4 billion for HIV programmes, making it one of the leading sources of funding for HIV programmes worldwide. The global population of people living with HIV continues to be large, numbering an estimated 33.3 million at the end of 2009 [1]. The Asian epidemic is still concentrated within specific high-risk populations. With such a large population, just a small increase could have catastrophic effects [3]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call